Medicines that contribute to improving health worldwide.
Our medicines aim to improve patients’ lives
AstraZeneca is responding to a changing world and an increasing burden of disease by advancing one of the strongest and most productive pipelines in our industry and working to deliver life-changing medicines to patients around the world.
In Switzerland, AstraZeneca has a broad portfolio of prescription drugs in the following therapeutic areas
PLENDIL 5 MG/10 MG/SENIOR 2,5 MG
TENORMIN/- MITE/- SUBMITE
LYNPARZA 50 MG KAPSELN
OXIS 6/12 TURBUHALER
VANNAIRTM 100/6, 200/6
Central nervous system
ESOMEP I.V., INJEKTIONS- /INFUSIONSPRÄPARAT
NEXIUM I.V., INJEKTIONS- /INFUSIONSPRÄPARAT
NEXIUM, GRANULAT ZUR ORALEN SUSPENSION
Patient safety is a top priority for AstraZeneca. That's why we review, document and analyse all information about adverse events and adverse reactions worldwide. Our aim is to monitor known risks and to identify unknown risks as quickly as possible and provide immediate information.
Help us by reporting side effects and adverse events!
Reporting side effects or adverse events
Tel.: +41 41 725 77 77
We need at least the following information:
- Which AstraZeneca drug was used?
- What event was observed?
- Who is affected? (Initials, sex, age of the patient)
- Contact details of the reporting person for further inquiries